MEDICASAFE, INC.

Basic Information

131 VARICK ST, STE 934
NEW YORK, NY, 10013-1443

Company Profile

n/a

Additional Details

Field Value
DUNS: 803410542
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Technology Enabled Specialty Pharmacy for Oral Oncology

    Amount: $224,751.00

    DESCRIPTION (provided by applicant): This SBIR Phase I application proposes development of the MedicaSafe ChemoCareRx, a technology- enabled specialty pharmacy service for oral oncology patients built ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Real-time Adherence and Risk Management of Opioid Therapies

    Amount: $993,194.00

    DESCRIPTION (provided by applicant): Following a highly successful Phase I award, this Phase II SBIR application proposes development of MedicaSafe Opioids - a risk management system for the treatment ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. Enhanced treatment management of opioid-dependence in an office-based setting

    Amount: $199,429.00

    DESCRIPTION (provided by applicant): The abuse and misuse of opiods is already a significant healthcare problem that is expected to escalate dramatically in the next decade. Traditionally, the treatme ...

    SBIR Phase I 2012 Department of Health and Human Services
  4. Real-time Adherence and Risk Management of Opioid Therapies

    Amount: $118,425.00

    DESCRIPTION (provided by applicant): This application proposes the development of the Adherence and Risk Management of Opioids with Realtime Electronic Data (ARMORED) drug system. The system uses a lo ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government